Brief: Kinnate Biopharma To Cut 56% Workforce
Jan 16 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC: COMPANY WILL REDUCE ITS WORKFORCE
BY
APPROXIMATELY 56% TO A TOTAL OF 12 REMAINING FULL-TIME EMPLOYEES
* KINNATE BIOPHARMA INC: ON JAN 9, COMMITTED TO IMPLEMENT
FURTHER
WORKFORCE REDUCTION
* KINNATE BIOPHARMA INC: EXPECTS TO INCUR ONE-TIME COSTS OF
APPROXIMATELY $1.2 MILLION IN Q1 OF 2024 IN CONNECTION WITH
WORKFORCE REDUCTION
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview